A DeBlasio

4.2k total citations · 1 hit paper
21 papers, 3.4k citations indexed

About

A DeBlasio is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, A DeBlasio has authored 21 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Hematology and 7 papers in Oncology. Recurrent topics in A DeBlasio's work include Retinoids in leukemia and cellular processes (8 papers), Acute Myeloid Leukemia Research (7 papers) and Cancer-related Molecular Pathways (4 papers). A DeBlasio is often cited by papers focused on Retinoids in leukemia and cellular processes (8 papers), Acute Myeloid Leukemia Research (7 papers) and Cancer-related Molecular Pathways (4 papers). A DeBlasio collaborates with scholars based in United States, Canada and Poland. A DeBlasio's co-authors include Pier Paolo Pandolfi, Zhugang Wang, Janice Gabrilove, Raymond P. Warrell, David A. Scheinberg, Elizabeth Calleja, P. Maslak, Suresh C. Jhanwar, Steven L. Soignet and Ethan Dmitrovsky and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Journal of Cell Biology.

In The Last Decade

A DeBlasio

21 papers receiving 3.3k citations

Hit Papers

Complete Remission after Treatment of Acute Promyelocytic... 1998 2026 2007 2016 1998 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A DeBlasio United States 16 2.6k 1.4k 673 397 388 21 3.4k
Susannah Waxman United States 33 2.9k 1.1× 1.5k 1.1× 501 0.7× 368 0.9× 286 0.7× 97 4.0k
Fausto Grignani Italy 20 3.0k 1.1× 1.2k 0.9× 677 1.0× 508 1.3× 292 0.8× 50 3.8k
Martin Ruthardt Germany 33 3.2k 1.2× 2.0k 1.4× 547 0.8× 374 0.9× 224 0.6× 85 3.9k
Shu-Min Xiong China 13 1.7k 0.6× 1.0k 0.7× 346 0.5× 365 0.9× 307 0.8× 22 2.3k
SR Frankel United States 12 2.1k 0.8× 1.6k 1.1× 341 0.5× 259 0.7× 468 1.2× 19 2.8k
Maurizio Gianni’ Italy 33 2.4k 0.9× 756 0.6× 303 0.5× 420 1.1× 357 0.9× 68 2.8k
Hélène Lapillonne France 22 1.5k 0.6× 905 0.7× 285 0.4× 331 0.8× 83 0.2× 57 2.7k
Steven D. Gore United States 28 2.3k 0.9× 1.1k 0.8× 564 0.8× 233 0.6× 55 0.1× 74 2.9k
Shangqin Guo United States 22 1.5k 0.6× 737 0.5× 431 0.6× 386 1.0× 106 0.3× 37 2.6k
L-J Gu China 4 1.8k 0.7× 1.2k 0.9× 159 0.2× 239 0.6× 409 1.1× 4 2.1k

Countries citing papers authored by A DeBlasio

Since Specialization
Citations

This map shows the geographic impact of A DeBlasio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A DeBlasio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A DeBlasio more than expected).

Fields of papers citing papers by A DeBlasio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A DeBlasio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A DeBlasio. The network helps show where A DeBlasio may publish in the future.

Co-authorship network of co-authors of A DeBlasio

This figure shows the co-authorship network connecting the top 25 collaborators of A DeBlasio. A scholar is included among the top collaborators of A DeBlasio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A DeBlasio. A DeBlasio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asai, Takashi, Megan Hatlen, Delphine Ndiaye‐Lobry, et al.. (2016). Generation of a novel, multi-stage, progressive, and transplantable model of plasma cell neoplasms. Scientific Reports. 6(1). 22760–22760. 4 indexed citations
2.
Asai, Takashi, Yan Liu, Silvana Di Giandomenico, et al.. (2012). Necdin, a p53 target gene, regulates the quiescence and response to genotoxic stress of hematopoietic stem/progenitor cells. Blood. 120(8). 1601–1612. 51 indexed citations
3.
Liu, Fan, Xinyang Zhao, Fabiana Perna, et al.. (2011). JAK2V617F-Mediated Phosphorylation of PRMT5 Downregulates Its Methyltransferase Activity and Promotes Myeloproliferation. Cancer Cell. 19(2). 283–294. 219 indexed citations
4.
Liu, Yan, Shannon Elf, Yasuhiko Miyata, et al.. (2009). p53 Regulates Hematopoietic Stem Cell Quiescence. Cell stem cell. 4(1). 37–48. 427 indexed citations
5.
Asai, Takashi, Yan Liu, Silvana Di Giandomenico, et al.. (2009). Necdin Regulates Hematopoietic Stem Cell Quiescence and Sensitivity to Genotoxic Stress.. Blood. 114(22). 379–379. 3 indexed citations
6.
Liu, Yan, Shannon Elf, Yasuhiko Miyata, et al.. (2007). Regulation of Hematopoietic Stem Cell Quiescence - A Novel Role for p53.. Blood. 110(11). 92–92. 2 indexed citations
7.
Lacorazza, H. Daniel, Yasushi Miyazaki, Antonio Di Cristofano, et al.. (2002). The ETS Protein MEF Plays a Critical Role in Perforin Gene Expression and the Development of Natural Killer and NK-T Cells. Immunity. 17(4). 437–449. 162 indexed citations
8.
Soignet, Steven L., P. Maslak, Zhugang Wang, et al.. (1998). Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide. New England Journal of Medicine. 339(19). 1341–1348. 1013 indexed citations breakdown →
9.
Wang, Huisheng, Mark A. Rubin, Eyal Fenig, et al.. (1997). Basic fibroblast growth factor causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory G1 events.. PubMed. 57(9). 1750–7. 64 indexed citations
10.
Tenson, Tanel, A DeBlasio, & Alexander S. Mankin. (1996). A functional peptide encoded in the Escherichia coli 23S rRNA.. Proceedings of the National Academy of Sciences. 93(11). 5641–5646. 79 indexed citations
11.
Soos, Timothy, Hiroaki Kiyokawa, Jing Yan, et al.. (1996). Formation of p27-CDK complexes during the human mitotic cell cycle.. PubMed. 7(2). 135–46. 207 indexed citations
13.
14.
Licht, Jonathan D., Christine Chomienne, André Goy, et al.. (1995). Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Blood. 85(4). 1083–1094. 270 indexed citations
15.
Levine, Kristi, et al.. (1994). Molecular diagnosis and monitoring of acute promyelocytic leukemia treated with retinoic acid.. PubMed. 8 Suppl 1. S116–20. 7 indexed citations
16.
Israeli, Ron, Wilson H. Miller, Sai L. Su, et al.. (1994). Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays.. PubMed. 54(24). 6306–10. 203 indexed citations
17.
Moasser, Mark M., A DeBlasio, & Ethan Dmitrovsky. (1994). Response and resistance to retinoic acid are mediated through the retinoic acid nuclear receptor gamma in human teratocarcinomas.. PubMed. 9(3). 833–40. 48 indexed citations
20.
Miller, William H., Akira Kakizuka, Stanley R. Frankel, et al.. (1992). Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia.. Proceedings of the National Academy of Sciences. 89(7). 2694–2698. 214 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026